Curanex Pharmaceuticals Inc (CURX) reporting calendar
Curanex Pharmaceuticals Inc files periodic reports with the SEC as CURX on Nasdaq. Atlas tracks 4 filed reports for this issuer, each linked to its original EDGAR accession.
- Next window
- 7 Aug 2026 – 20 Sep 2026
- Latest report
- 10-Q
- Period ended
- 31 Mar 2026
- Filed
- 14 May 2026
- Reports on record
- 4
How this window is derived. Derived from this issuer's own filing history: 4 periods at a median 92-day cadence, filed a median 59 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.
Open CURX market profile
Latest filing on SEC EDGAR ↗
Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 10-Q | 31 Mar 2026 | 14 May 2026 | 44 days | 0001493152-26-022892 |
| 10-K | 31 Dec 2025 | 30 Mar 2026 | 89 days | 0001493152-26-013677 |
| 10-Q | 30 Sep 2025 | 17 Nov 2025 | 48 days | 0001493152-25-023710 |
| 10-Q | 30 Jun 2025 | 9 Sep 2025 | 71 days | 0001493152-25-012880 |
Source: SEC EDGAR company submissions for CIK 0002025942. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.